Prospective
analysis of the panel in clinical setting is
needed next to validate this panel of
biomarkers as an effective screening tool
for ovarian cancer.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.